Introduction
============

Myogenesis is the key process of muscle development occurring during embryogenesis, with the final number of muscle cells nearly established just before birth. Myogenesis begins with the conversion of pluripotent cells into myoblast precursors, which, depending on extracellular signals, undergo migration or proliferation. Afterwards, the precursors stop dividing and some form uninuclear totipotential cells, ie, satellite cells, while the remaining myoblasts begin to differentiate. Subsequently, they undergo fusion to form multinucleated myotubes, which become muscle cells. The process of formation of muscle is almost completed at the time of hatching, and the numbers of muscle fibers and nuclei in muscle cells are almost fixed.[@b1-ijn-6-3163],[@b2-ijn-6-3163] Satellite cells are potentially mitotically active myogenic cells, located at the periphery of muscle fibers, between the sarcolemma and the basement membrane of developed muscle fibers. In contrast to muscle cells, satellite cells retain the capacity for DNA replication and mitotic division, and have the ability to proliferate in response to muscle damage, hence they support the process of muscle regeneration in postnatal life.[@b3-ijn-6-3163] In the muscles of birds, satellite cells appear between day 13 and day 16 of embryogenesis.[@b4-ijn-6-3163]

The factor responsible for renewing the pool of satellite cells is the protein paired-box transcription factor-7 (*Pax-7*).[@b1-ijn-6-3163] It affects the transcriptional activation of genes and regulates the development of myogenic cells.[@b5-ijn-6-3163] In *Pax-7*-deficient neonatal mice, a lack of satellite cells in crossstriated skeletal muscles was observed, suggesting that this is a key factor responsible for the formation of satellite cells,[@b6-ijn-6-3163] and is therefore an excellent marker of satellite cell development.[@b7-ijn-6-3163]

During embryogenesis, the activity of myoblasts and satellite cells is highly affected by the extracellular matrix, consisting of an organized network of proteins and polysaccharides (collagen, proteoglycans, and glycoproteins).[@b2-ijn-6-3163] Proteoglycans play an important role in the differentiation of muscle, regulating the reactivity of myoblasts and satellite cells by acting on basic fibroblast growth factor-2 (*FGF-2*) and the family of transforming growth factors.[@b8-ijn-6-3163] The interaction between muscle cells and *FGF-2* depends on several factors, including the presence of heparan sulfate (HS) in the extracellular matrix. HS mediates interactions with a variety of extracellular ligands and participates in the proliferation, differentiation, migration, and adhesion of cells.[@b9-ijn-6-3163] The genetic capacity for proper development of muscle tissue in embryos of animals and humans may be hampered by a shortage of sulfur signaling compounds in the extracellular matrix, especially glycosaminoglycans.[@b10-ijn-6-3163]

The unique properties of gold nanoparticles (nano-Au) are due to their small size, much larger surface area per unit mass compared with larger particles, and a greater proportion of atoms exposed on the surface of the particles, making them much more reactive than larger particles.[@b11-ijn-6-3163] Nano-Au exhibit a strong affinity for thiol groups, which allows efficient and selective bonding with intracellular compounds.[@b12-ijn-6-3163] Nano-Au can penetrate cells by endocytosis, and they can be carriers of pharmaceuticals, nucleic acids, and other biologically active substances.[@b13-ijn-6-3163],[@b14-ijn-6-3163] The application of drugs conjugated with nano-Au has shown high precision in the delivery of drugs, and significantly decreased their doses.[@b15-ijn-6-3163]

It has been demonstrated that low concentrations of nano-Au are not toxic to human cells,[@b16-ijn-6-3163] but cause toxicity in zebrafish[@b17-ijn-6-3163] and when using higher doses deposited in animal tissues.[@b18-ijn-6-3163] The present experiment was not designed to evaluate potential toxicity of nano-Au but to measure their effects on muscle development when used in a small concentration (50 mg/L solution).

Nano-Au can create biocomplexes with organic compounds in the process of self-assembly (self-organization) using noncovalent bonds.[@b19-ijn-6-3163],[@b20-ijn-6-3163] The phenomenon of self-organization allows the creation of new structures in a simple and natural way, and in this respect, nano-Au seem to be a promising candidate for self-assembly processing of biomolecules like HS.

It was hypothesized that HS as an essential compound for myogenesis and nano-Au as highly reactive compounds can affect muscle development as a consequence of molecular regulation of muscle cell formation, and that these effects may be enhanced by a complex of HS conjugated with nano-Au. The objective of the present study was to determine the effect of administration of HS, nano-Au, and the nano-Au+HS complex on the morphological and molecular characteristics of muscle development, particularly on the number of muscle and satellite cells.

Materials and methods
=====================

Solutions
---------

The hydrocolloid of nano-Au (50 mg/L) obtained from Nano-Tech (Warsaw, Poland) was produced by an electric nonexplosive patented method (Polish patent 3883399) from high purity metals (99.99%) and high purity demineralized water. The structure of the nanoparticles was visualized by a JEM-1220 transmission electron microscope (TEM) (JEOL, Tokyo, Japan) and the diameter ranged from 5--70 nm ([Figure 1](#f1-ijn-6-3163){ref-type="fig"}). HS was provided by Iduron Ltd (Manchester, United Kingdom) as a K5 polysaccharide derivative. Produced in *Escherichia coli* K5, it has a repeat unit structure identical to the nonsulfated regions of HS. The highly sulfated derivative was applied where sulfation was carried out by chemical and enzymatic methods. This polymer was N-sulfated, O-sulfated at C-6 of α-N-sulfo-D-glucosamine, C2 and C3 of glucuronic acid, and had variable O-sulfation at C3 of α-N-sulfo-D-glucosamine.

HS was conjugated with nano-Au by mixing the HS water solution (0.032 mg/L) with nano-Au hydrocolloid (50 mg/L) in an ultrasonic bath (Sonorex Super RK 514 H; Bandelin Electronic, Berlin, Germany) for 30 minutes at 36°C at a frequency of 50/60 Hz.

Experiment
----------

Fertilized chicken eggs (n = 350) were randomly divided into four treatment groups: (1) control group (without injection), (2) nano-Au group (with nano-Au solution), (3) HS group (with HS solution), and (4) nano-Au+HS group (with mixture of nano-Au and HS). The experimental solutions were given in ovo on the first day of incubation by injecting 500 μL of each solution into the air sack.

The embryos were evaluated on day 20 of incubation. The embryos were weighed together with the yolk sack, decapitated, and blood samples from the carotid artery were with-drawn and collected in Eppendorf polymerase chain reaction (PCR) tubes (Eppendorf AG, Hamburg, Germany). Samples were incubated at room temperature until clotting and then centrifuged for 10 minutes (14,500 × g). The resulting blood serum samples were stored at −30°C until further analysis. The liver, heart, and spleen were collected and weighed. Samples of the breast muscles (4 × 6 × 2 mm) were collected in liquid nitrogen for immunohistochemistry, enzyme-linked immunosorbent assay, and confocal microscopy preparations or fixed in glutaraldehyde for electron microscopy preparation or collected in RNAlater^®^ ribonucleic acid (RNA) Stabilization Solution (Applied Biosystems/Ambion, Austin, TX) for gene expression analysis.

The experimental procedures were approved by, and complied with the guidelines of, the National Ethical Committee of Animal Experimentation, Poland.

Analytical methods
------------------

### Evaluation of embryo development

Embryo development was evaluated on day 20 of embryogenesis. The morphological structure was compared with the standard described by Hamburger and Hamiliton.[@b21-ijn-6-3163]

Concentrations of magnesium, calcium, phosphorus, triglycerides, cholesterol in very-low-density lipoprotein, glucose, and the activities of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and lactate dehydrogenase in blood serum were measured by dry chemistry methods using the chemical analyzer Johnson and Johnson Vitros^®^ DT60 II (Ortho-Clinical Diagnostics Inc, Raritan, NJ).

### Immunohistochemistry

Frozen (−80°C) breast muscles were cut on a cryostat (Leica CM1900; Leica Microsystems GmbH, Wetzlar, Germany) into 7 μm thick sections and put on microscopic slides covered with poly-L-lysine (Waldemaar Knittel Gläsbearbeitungs, Braunschweig, Germany). Fixation was performed in 4% paraformaldehyde for 30 minutes and then in 0.5% Tween^®^ 20 (Bio-Rad Laboratories, Hercules, CA) for 5 minutes. Fixed slides were kept at −20°C until further processing.

Specimens were hydrated with 10 minutes incubation in phosphate buffered saline (PBS; Sigma-Aldrich Corporation, St Louis, MO) at room temperature. Staining was performed in the dark, using a solution containing 1 μg/mL 4′,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) in PBS. The incubation lasted for 20 minutes and was followed by a triple rinse of the slides with PBS. The specimens were then coverslipped using ProLong^®^ Gold Antifade Reagent (Life Technologies, Carlsbad, CA).

Fixed preparations were hydrated for 10 minutes in PBS at room temperature. Specimens were then incubated in a solution containing 2% goat serum (Sigma-Aldrich) and 1% bovine serum albumin (Sigma-Aldrich) for 20 minutes at room temperature to block nonspecific binding. In the next step, the specimens were incubated with the primary antibody (*Pax-7*; Santa Cruz Biotechnology, Inc, Santa Cruz, CA) diluted 1:200 for 60 minutes at room temperature. Subsequently, excess antibodies were washed off with three rinses of PBS and the secondary antibody (antimouse immunoglobulin G--fluorescein isothiocyanate antibody produced in goat; Sigma-Aldrich) diluted 1:1000 was applied. After a triple rinse of the slides in PBS, DAPI staining was performed.

### Microscopy

Immunohistochemically stained specimens were visualized using a FluoView FV-1000 confocal microscope equipped with FV10-ASW version 1.4. software (Olympus Corporation, Warsaw, Poland). The pictures were analyzed using the cellSens^®^ Dimension program (Olympus).

The breast muscles were examined using a Quanta^™^ 200 scanning electron microscope (SEM; FEI Company, Hillsboro, OR), using environmental SEM operating mode and by TEM. For observations with SEM, samples were stored at −30°C. Frozen (−30°C) samples were cleanly cut with a scalpel into 1 mm thick sections on frozen pieces of wax. While still frozen, a sample section was placed on a Peltier table within a standard cooled microscope column (at −5°C for blood vessels and −10°C for cartilage) in the sample chamber under high vacuum (10^−5^ Torr). For observations with TEM, immediately after dissection, tissues were cut into pieces of about 1 mm^3^ and fixed in a 2.5% glutaraldehyde solution (Sigma-Aldrich) in 0.1 M phosphate buffer (pH 6.9). Samples were then rinsed in the same buffer and transferred to a 1% osmium tetroxide solution (Sigma-Aldrich) in 0.1 M phosphate buffer (pH 6.9) for 1 hour. Subsequently, the samples were rinsed in distilled water, dehydrated in an ethanol gradient, and impregnated with epoxy embedding resin (Fluka Epoxy Embedding Medium Kit; Sigma-Aldrich). The next day, samples were embedded in the same resin and baked for 24 hours at 36°C. The blocks were then transferred to a 60°C incubator and baked for another 24 hours. The blocks were cut into ultrathin sections (50--80 nm) using an ultramicrotome (Ultratome III; LKB Products, Bromma, Sweden) and transferred onto copper grids, 200 mesh (Agar Scientific Ltd, Stansted, Essex, United Kingdom). Subsequently, the sections were contrasted using uranyl acetate dihydrate (Sigma Aldrich) and lead citrate (lead (II) citrate tribasic trihydrate; Sigma-Aldrich).

### Gene expression of *Pax-7* and *FGF-2* at messenger RNA (mRNA) level

The tissue dissected from the breast muscle was homogenized in TRIzol^®^ Reagent (Life Technologies), and total RNA was extracted according to the manufacturer's instructions. The RNA samples were purified, using the SV Total RNA Isolation System (Promega Corporation, Madison, WI) and quantified using a NanoDrop ND 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA). Using reverse transcriptase with oligo(dT) (Promega) and random primers (TAG Copenhagen A/S, Copenhagen, Denmark), 2 mg of total RNA was reverse transcribed, after which real-time PCR was performed with complementary DNA and gene-specific primer pairs (TAG Copenhagen; [Table 1](#t1-ijn-6-3163){ref-type="table"}) mixed with LightCycler^®^480 SYBR Green I Master mix (Roche Applied Science, Penzberg, Germany) in a LightCycler^®^480 Real-Time PCR system (Roche Applied Science). The samples were first denatured for 5 minutes at 95°C and then amplified using 45 cycles of 10 seconds at 95°C (denaturation), 10 seconds at 60°C--62°C (annealing), and 9 seconds at 72°C (elongation), followed by quantification. A melting curve program (56°C--97°C with a heating rate of 0.11°C/ second and five acquisitions per 1°C) was applied to verify the specificity of the product. For each complementary DNA, the reaction was performed in triplicate. For analyses, relative quantification was applied with *ACTB* and *EEF1*-α used as the housekeeping genes.

### Gene expression of *FGF-2* at protein level

Frozen breast muscle tissue samples were homogenized on ice using RIPA lysis and extraction buffer (Thermo Fisher Scientific) and a Polytron^®^ PT 2100 homogenizer (Kinematica AG, Lucerne, Switzerland). Homogenates were left on ice for 30 minutes and were subsequently centrifuged for 20 minutes (4°C, 12,500 rpm). The supernatant was collected in chilled Eppendorf PCR tubes (Eppendorf AG). Supernatant samples were divided into two equal portions. One was used to evaluate the total protein concentration (Total Protein Kit, Micro Lowry, Peterson's Modification; Sigma-Aldrich). The second portion was used to perform the enzyme-linked immunosorbent test, using an Enzyme-linked Immunosorbent Assay Kit for Gallinaceous FGF-2 (USCN Life Science, Tokyo, Japan). Reagents and plates were prepared accordingly to the manufacturer's standard procedure and incubated for 25 minutes under standard conditions. The degree of absorption was measured in a microplate reader Infinite^®^ M200 PRO (Tecan Deutschland GmbH, Crailsheim, Germany).

### Statistical analysis

Statistical analysis of data was carried out using a two-way analysis of variance test (Statgraphics Plus version 4.1; Stat-Point Technologies, Inc, Warrenton, VA). The model included two factors (nano-Au and HS treatments) and interactions between the factors. Significant effects were stated when *P* \< 0.05.

Results
=======

In the present experiment, embryos treated with HS had lower mortality than other groups. Nano-Au, HS, and nano-Au+HS complex did not affect embryo weight or the weight of organs, except for the heart being slightly smaller with HS treatment ([Table 2](#t2-ijn-6-3163){ref-type="table"}). Furthermore, there was no significant effect on the measured biochemical indices in blood ([Table 3](#t3-ijn-6-3163){ref-type="table"}).

To examine the influence of nano-Au and HS on muscle development, the number of nuclei was determined (DAPI staining) in the breast muscle, showing increased number of nuclei in treated embryos ([Figure 2](#f2-ijn-6-3163){ref-type="fig"}). The counted number of nuclei was significantly higher in embryos treated with nano-Au and nano-Au+HS than in the control group, and there was highly significant interaction between nano-Au and HS treatments ([Table 4](#t4-ijn-6-3163){ref-type="table"}).

Breast muscle tissue was visualized by SEM, using the environmental SEM operating mode which allows observation with minimal distortion to the muscle structure. There were visual changes in the structure of the breast muscle in the groups treated with injections compared to the embryos from the control group ([Figure 3](#f3-ijn-6-3163){ref-type="fig"}). In the control group, the muscle fibers formed the most compact structure and the surface of individual muscle fascicles was smaller compared to the treatment groups. Furthermore, the distances between fascicles were greater and the area of fascicles was longer with sharper structures in the control group than in the treatment groups. Empty areas, which were seen around fascicles in the control group, were much smaller than in the treatment groups. In embryos treated with nano-Au, HS, and nano-Au+HS, muscle fibers were organized in more rounded and well-developed fascicles, located equally within muscle. In the HS-treated groups, the connective tissue seen between muscle fascicles was better developed than in the other embryos. The structure of the muscle cross-section in the nano-Au+HS group was the most homogeneous and mature. Fascicles were the most rounded and filled with myofibers. The space around them also showed better connective tissue structure.

The evaluation of the morphology of breast muscles was carried out using TEM. While analyzing transverse section images of muscle samples from the control group, an enlargement area was seen between cells and cells were more rounded and less angular with a slightly stippled cytoplasm. Within cells, cylindrical myofibrils were seen; however, in the control group they were loosely spaced with larger spaces between myofibers than in the treatment groups. Also, myomere decay, unification of actin and myosin filaments, loose connective tissue, and occasional myelin structures were observed ([Figure 4](#f4-ijn-6-3163){ref-type="fig"}). Muscles from the nano-Au group were characterized by contracted cells and bigger myocytes. In the muscles from the HS group, a higher number of satellite muscle cells were seen. Moreover, angular, homogeneous myofibers were observed close to each other. These muscles were more developed compared with the control group. In the muscles from the nano-Au+HS group, homogenous and closely located (packed) muscle cells were seen. Within cells, myofilaments were clearly seen and numerous mitochondria and a large number of satellite cells were also observed.

From the morphometric measurements, the number of satellite cells and muscle cells were determined ([Table 4](#t4-ijn-6-3163){ref-type="table"}). HS and nano-Au+HS increased the number of muscle cells and satellite cells, compared to the control and nano-Au groups.

To confirm the effects on the number of satellite cells, muscle samples were stained for *Pax-7* protein and observed with a confocal microscope ([Figure 5](#f5-ijn-6-3163){ref-type="fig"}). The muscles from embryos treated with HS and nano-Au+HS had a larger number of clusters of *Pax-7* protein than the muscles from the nano-Au and control groups.

To confirm the results on the molecular level, gene expression of *Pax-7* and *FGF-2* in the breast muscle was measured ([Table 5](#t5-ijn-6-3163){ref-type="table"}). At the mRNA level, HS significantly increased expression of *Pax-7* and significantly reduced the expression of *FGF-2*. However, there was no effect of nano-Au and no interaction between nano-Au and HS.

Discussion
==========

In the present study, the chicken embryo was chosen as the animal model. It has a rapid rate of growth and its embryonic development is described in detail.[@b21-ijn-6-3163] The embryo is independent from the mother,[@b22-ijn-6-3163] it is highly sensitive to harmful factors,[@b23-ijn-6-3163] and it has been used as a suitable model for cancer therapy research,[@b24-ijn-6-3163] the determination of bacterial invasiveness,[@b25-ijn-6-3163] and new drug delivery systems development.[@b26-ijn-6-3163]

Analysis of the present results led to the conclusion that administration of nano-Au, HS, and nano-Au+HS did not negatively affect the growth and development of chicken embryos. The results from other investigations suggest that, up to a certain concentration, nano-Au are not harmful to an organism, but with increasing concentrations they may have harmful effects.[@b16-ijn-6-3163]--[@b18-ijn-6-3163],[@b27-ijn-6-3163],[@b28-ijn-6-3163] The present study was not undertaken to evaluate potential toxicity of nano-Au, however, it confirmed the lack of harmful effects of nano-Au administered in small quantities (concentration: 50 mg/L, dose: 500 μL). Nano-Au did not negatively affect development of embryos (mortality, organ weight, and homeostasis). Nevertheless, the present results are from a short term study over 20 days of embryogenesis; because nano-Au can penetrate most tissues,[@b29-ijn-6-3163]--[@b31-ijn-6-3163] their potentially negative effects may take place later in life.

In comparison to Au, HS is a natural component of tissues and given at the concentration of 0.032 mg/L and the dose of 500 μL had no adverse effects on embryonic development; moreover, HS reduced the mortality of embryos and decreased the heart weight compared to the other groups. The heart develops from cardiomyocyte precursors and even at the beginning of embryogenesis works together with the developing outer network of blood vessels.[@b22-ijn-6-3163] According to Ausprunk,[@b32-ijn-6-3163] HS is involved in the differentiation and development of arterial and venous vessels of the chorioallantoic membrane. A key factor for vascular development is vascular endothelial growth factor.[@b33-ijn-6-3163] HS can partially activate an inactive form of vascular endothelial growth factor, prolonging its biological activity.[@b34-ijn-6-3163] Furthermore, addition of a sulfated oligosaccharide enhances angiogenesis and stabilizes the capillary network of new blood vessels.[@b10-ijn-6-3163],[@b35-ijn-6-3163] Thus, a properly developed system of blood vessels of the correct diameter may decrease the resistance of peripheral vessels and, consequently, slightly decrease the force of heart contractions, leading to a proper heart weight. It should also be noted that the activity of alanine aminotransferase, aspartate aminotransferase, and other biochemical parameters of blood did not change, which otherwise could be the sign of distortion in the homeostasis of the organism, including the circulatory system.

Assessing the dynamics of muscle development, it was found that the total number of DAPI-labeled nuclei increased after in ovo HS injection, indicating enhanced dynamics of embryonic muscle development. Within the muscle tissue of the developing chicken embryo, nuclei of various cells can be observed: multinuclear muscle cells, connective tissue cells, blood cells, nerve cells, satellite cells, and other stem cells, but the muscle cells and muscle stem cells are dominant.[@b2-ijn-6-3163] The analysis of images obtained from SEM and TEM clearly showed an increase in the number of muscle cells after treatment with HS. To explain this phenomenon, two mechanisms could be considered; the first may indicate a scarcity of HS, which is essential for muscle development while the second may point to the stimulating effects of HS. In the present experiment, morphological defects seen in the control group may confirm the first mechanism that the quantity of HS or it precursors in the egg was not sufficient for optimal muscle development.

The mechanism of formation of muscle structures, depending on the chemical composition of the extracellular matrix, is not fully known. Myogenesis starts early in embryonic development and *FGF-2* plays a key role in mesoderm induction.[@b36-ijn-6-3163] This factor stimulates proliferation and inhibits cell differentiation[@b37-ijn-6-3163] by suppressing the transcription of myogenin.[@b38-ijn-6-3163] HS allows cells to bind *FGF-2* and with an increasing number of sulfur groups, the binding efficiency increases,[@b39-ijn-6-3163],[@b40-ijn-6-3163] while a loss of sulfur groups blocks glycosaminoglycan activity.[@b41-ijn-6-3163] Inhibition of proliferation because of HS deficiency and premature cell differentiation is likely to reduce the number of cells in the final stages of embryonic development and ultimately may lead to defective tissue structure, especially in intensively growing organisms.[@b42-ijn-6-3163],[@b43-ijn-6-3163]

In the present experiment, expression of *FGF-2* at the mRNA level in the HS groups decreased more than fourfold compared to the control group. The evaluation of morphological and molecular indices of muscle development was carried out at day 20 of incubation, hence at the end of embryogenesis, just before hatching. On day 20 of embryonic development, the process of muscle development is almost finished and the number of muscle cells is almost stable. This was manifested by the reduced expression of *FGF-2* at mRNA level in HS muscles, indicating that the process of muscle fiber formation was completed. At the protein level, the concentration of *FGF-2* protein was not significantly affected by HS, probably because protein expression occurs as a consequence of gene expression and is associated with a delay.

The effect of HS on *FGF-2* expression at the mRNA level may be explained by an increased affinity of *FGF-2* for its receptor,[@b44-ijn-6-3163]--[@b46-ijn-6-3163] thereby enhancing the *FGF*/FGF receptor interaction. It has also been demonstrated that both HS and heparin may increase the surface concentration of *FGF-2*, as well as assist in ligand dimerisation;[@b46-ijn-6-3163]--[@b48-ijn-6-3163] consequently, signaling activities of *FGF-2* might be more efficient in muscles enriched with HS. On the other hand, other mechanisms have also been suggested. The results from Wiedlocha et al[@b49-ijn-6-3163] indicate a receptor-independent mechanism for *FGF-1* stimulation of proliferation. This may be true for *FGF-2* as both growth factors bind to similar receptors. Therefore, signals important for cell proliferation can be initiated either via the FGF receptors or independent of them. Furthermore, Quarto and Amalric[@b50-ijn-6-3163] reported that *FGF-2* stimulated plasminogen activator expression in L6 rat myoblasts devoid of functional FGF receptor. They suggested that the signal is transduced through HS proteoglycans. This may also explain the decreased mRNA expression of *FGF-2* in HS-treated embryos, which could have been caused by increased efficiency of *FGF-2* and thereby diminished the requirement for the synthesis of this molecule.

TEM image analysis showed an increased number of satellite cells in the muscles of embryos treated with HS. The regeneration of muscle fibers in the postnatal period is highly dependent on the number of satellite cells formed during embryogenesis. Furthermore, the number of muscle satellite cells decreases with age. In chickens, in the late phase of muscle growth, it declines to less than 5% of the total number of muscle fibers.[@b51-ijn-6-3163] Thus, an increased pool of these cells during embryogenesis may protect from muscle atrophy later in life.[@b52-ijn-6-3163]

To elucidate the effect of HS on muscle development, a number of cells containing protein *Pax-7* and its gene expression at the mRNA level were estimated. *Pax-7* is localized in the nucleus of satellite cells and is a recognized marker of these cells.[@b7-ijn-6-3163] Treatments with HS contributed to the increased number of *Pax-7* positive cells and expression of the gene. In the present experiment, expression of *FGF-2* at the mRNA level, close to hatching, was decreased in the HS groups. This may be related to the *Pax-3* and *Pax-7* genes, which are indirectly involved in the down regulation of *FGF-2* via a feedback mechanism.[@b53-ijn-6-3163] Taking into consideration the fact that HS affected both the number of satellite cells as well as muscle cells, this indicates that HS modified the whole sequence of events during the maturation of muscles, increasing the formation of muscle fibers, and increasing the formation and incorporation of satellite cells in the breast muscle at the end of embryogenesis.

Assessing the impact of nano-Au on muscle development, it was measured that nano-Au increased the number of nuclei and enlarged the areas of fibers in the breast muscle. However, there was no effect of nano-Au on the number of satellite cells or on the number of muscle cells. These results may indicate that nano-Au could boost the number of nuclei in a single muscle fiber and/or increase the number of other cells. Certainly, more research is needed to elucidate the mechanisms of muscle fiber enlargement.

The present results have shown that cell and/or tissue requirements for functional compounds like sulfur-containing molecules may be a critical point for proper maturation and functioning of muscle. Moreover, nano-Au did not influence the homeostasis of the embryo organism, suggesting that they might be used as carriers of drugs and other bioactive compounds. Although these results were obtained from chicken embryos, which develop quickly, they indicate the potential applicability of HS, nano-Au, and complexes of these materials for nutritional and therapeutic procedures.

Conclusion
==========

Nano-Au and HS, administered in ovo to chicken embryos on the first day of embryogenesis, did not adversely affect mortality, organ weight, and homeostasis of the embryos by day 20 of embryonic development. HS improved the development and maturation of breast muscle by increasing the number of myocytes, satellite cells, and nuclei, and by increasing area of muscle fibers. Furthermore, the nano-Au+HS complex contributed to the increased number of myocytes and nuclei, and enlarged area of muscle fibers. The results indicate that the administration of HS and nano-Au affects muscle development and that this effect is enhanced by conjugating HS with nano-Au.
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![Image of hydrocolloid of gold nanoparticles visualized using transmission electron microscopy.](ijn-6-3163f1){#f1-ijn-6-3163}

![Images of nuclei (blue), stained with 4′,6-diamidino-2-phenylindole, in the cross-section of the breast muscle of a chicken embryo on day 20 of incubation visualized using a confocal microscope. (**A**) Control, (**B**) gold nanoparticles, (**C**) heparan sulfate, and (**D**) gold nanoparticles and heparan sulfate complex.](ijn-6-3163f2){#f2-ijn-6-3163}

![Images of the ultrastructure of the cross-section of the breast muscle of a chicken embryo on day 20 of incubation visualized using scanning electron microscopy (environmental scanning electron microscope mode). (**A**) Control, (**B**) gold nanoparticles, (**C**) heparan sulfate, and (**D**) gold nanoparticles and heparan sulfate complex.](ijn-6-3163f3){#f3-ijn-6-3163}

![Images of the ultrastructure of the cross-section of the breast muscle of a chicken embryo on day 20 of incubation visualized using transmission electron microscopy. (**A**) Control, (**B**) gold nanoparticles, (**C**) heparan sulfate, and (**D**) gold nanoparticles and heparan sulfate complex.](ijn-6-3163f4){#f4-ijn-6-3163}

![Images of Pax-7 positive nuclei, shown as an overlaid image of 4′,6-diamidino-2-phenylindole-stained nuclei (blue) and Pax-7 nuclei stained with fluorescein isothiocyanate (green), in the cross-section of the breast muscle of a chicken embryo on day 20 of incubation visualized using a confocal microscope. (**A**) Control, (**B**) gold nanoparticles, (**C**) heparan sulfate, and (**D**) gold nanoparticles and heparan sulfate complex.](ijn-6-3163f5){#f5-ijn-6-3163}

###### 

Oligonucleotide sequences used in polymerase chain reaction

  Gene       Size         Primer sequences (5′ to 3′)
  ---------- ------------ --------------------------------------
  *ACTB*     ca. 169 bp   Forward: GTC CAC CTT CCA GCA GAT GT
                          Reverse: ATA AAG CCA TGC CAA TCT CG
  *EEF1-*α   ca. 85 bp    Forward: AGC AGA CTT TGT GAC CTT GCC
                          Reverse: TGA CAT GAG ACA GAC GGT TGC
  *FGF-2*    ca. 151 bp   Forward: GGC ACT GAA ATG TGC AAC AG
                          Reverse: TCC AGG TCC AGT TTT TGG TC
  *PAX-7*    ca. 135 bp   Forward: CCA GTA GAG ACA GGC CAA GC
                          Reverse: GGA GTT GGG AAG GAG TAG GG

###### 

Mortality and average weight of embryos and organs without (--) or with gold nanoparticles and heparan sulfate

                  Treatment   ANOVA                                                 
  --------------- ----------- ------- ------ ------ ------- ------- ------- ------- -------
  Mortality, %    13.6        15.6    9.52   8.33                                   
  Embryo, % e.w   85.1        84.9    85.0   85.0   0.615   0.29    0.917   0.26    0.045
  Liver, % b.w    1.66        1.75    1.72   1.69   0.074   0.030   0.447   0.029   0.613
  Heart, % b.w    0.60        0.59    0.63   0.56   0.347   0.011   0.002   0.013   0.099
  Spleen, % b.w   0.05        0.04    0.05   0.04   0.066   0.002   0.094   0.002   0.844

**Abbreviations:** % e.w, % of egg weight; % b.w, % of body weight; ANOVA, analysis of variance; HS, heparan sulfate; nano-Au, gold nanoparticles; SEM, standard error of the mean.

###### 

Biochemical indices in the blood serum of chicken embryos without (--) or with gold nanoparticles and heparan sulfate

                                     Treatment   ANOVA                                                 
  ---------------------------------- ----------- ------- ------ ------ ------- ------- ------- ------- -------
  Magnesium (mmol/L)                 0.75        0.88    0.75   0.88   0.702   0.516   0.477   0.129   0.882
  Calcium (mmol/L)                   2.70        2.71    2.45   2.96   0.980   0.136   0.092   0.038   0.752
  Phosphorus (mmol/L)                1.73        1.69    1.71   1.70   0.651   0.060   0.916   0.059   0.751
  Triglycerides (mmol/L)             0.78        0.75    0.79   0.73   0.714   0.062   0.529   0.062   0.962
  Cholesterol-VLDL (mmol/L)          0.35        0.35    0.36   0.34   0.904   0.039   0.740   0.036   0.928
  Glucose (mmol/L)                   10.6        10.2    10.1   10.2   0.502   0.51    0.689   0.507   0.899
  Alkaline phosphatase (U/L)         658         636     567    727    0.812   64.2    0.093   54.2    0.620
  Aspartate aminotransferase (U/L)   144         162     181    125    0.512   19.2    0.050   29.2    0.138
  Alanine aminotransferase (U/L)     11.7        10.2    13.2   8.70   0.527   1.707   0.075   1.88    0.839
  Lactate dehydrogenase (U/L)        2720        3047    2945   2822   0.223   184.2   0.643   192.3   0.399

**Abbreviations:** ANOVA, analysis of variance; HS, heparan sulfate; nano-Au, gold nanoparticles; SEM, standard error of the mean; VLDL, very-low-density lipoprotein.

###### 

Morphometry of the breast muscle of chicken embryos without (--) or with gold nanoparticles and heparan sulfate

                                                                                      Treatment   ANOVA                                                
  ----------------------------------------------------------------------------------- ----------- ------- ------ ------ ------- ------ -------- ------ --------
  Number of myocytes/10,000 μm^2^[\*](#tfn3-ijn-6-3163){ref-type="table-fn"}          23.0        27.5    18.5   32.1   0.197   3.21   0.0000   2.88   0.024
  Number of satellite cells/10,000 μm^2^[\*](#tfn3-ijn-6-3163){ref-type="table-fn"}   7.1         8.4     6.8    8.7    0.213   0.91   0.0330   0.72   0.452
  Fiber area (μm^2^)[\*](#tfn3-ijn-6-3163){ref-type="table-fn"}                       19.9        25.0    19.2   21.4   0.002   1.06   0.0007   1.30   0.023
  Number of nuclei/10,000 μm^2^[\*\*](#tfn4-ijn-6-3163){ref-type="table-fn"}          16.1        19.7    15.7   21.4   0.004   0.84   0.0009   1.03   0.0009

**Notes:** Transmission electron microscope;

confocal microscope.

**Abbreviations:** ANOVA, analysis of variance; HS, heparan sulfate; nano-Au, gold nanoparticles; SEM, standard error of the mean.

###### 

Expression of *PAX-7* and *FGF-2* on the messenger ribonucleic acid level, normalized to *ACTB*, and on the protein level in the breast muscle of chicken embryos without (--) or with gold nanoparticles and heparan sulfate

                                                                       Treatment   ANOVA                                                  
  -------------------------------------------------------------------- ----------- ------- ------ ------ ------- ------- -------- ------- -------
  *PAX-7*[\*](#tfn6-ijn-6-3163){ref-type="table-fn"}                   0.80        0.98    0.57   1.21   0.435   0.156   0.0086   0.358   0.845
  *FGF-2*[\*](#tfn6-ijn-6-3163){ref-type="table-fn"}                   2.63        2.70    4.40   0.94   0.950   0.705   0.0024   0.117   0.806
  *FGF-2* pg/mg protein[\*\*](#tfn7-ijn-6-3163){ref-type="table-fn"}   132         127     144    118    0.716   8.4     0.217    10.3    0.119

**Notes:** Messenger ribonucleic acid level;

protein level.

**Abbreviations:** ANOVA, analysis of variance; HS, heparan sulfate; nano-Au, gold nanoparticles; SEM, standard error of the mean.
